Regulating in the Connected Health World, PharmaVoice contributor

Picture of the Whitehouse

Pharmaceutical regulation is both a hindrance and a necessity.  In September 2013, the FDA issued a final guidance for mobile medical apps.  This guidance provides clarity regarding which mobile apps are the focus of FDA oversight and which are not.  Together with January 2014’s draft social guidance we can begin to pain a picture in the FDA’s role in oversight, safety, and privacy.

Read more:


Related posts

Leave a Comment